SINGAPORE, June 29 /PRNewswire-Asia/ -- Rising healthcare standards together with the growing demand for more affordable treatment will keep the Asian market for medical tourism buoyant, according to experts speaking at the Healthcare Travel Exhibition & Congress today at Fairmont Hotel, Singapore. Worldwide gross medical tourism revenue is projected to grow from US$56 billion to reach US$100 billion by 2012, with Asia as a major driver of this growth.
"Buoyed by the success stories of earlier waves of medical tourists, consumers, insurance companies as well businesses fully recognise the reliability and affordability of going overseas for medical procedures. Patients who choose to undergo treatments in Asia can pay just 10% of the cost of comparable treatment conducted in developed countries like the United States or United Kingdom. This differential cost, coupled with today's sophisticated travel industry, provides an excellent catalyst to the growth of medical tourism," said Mr. Andrew Keable, Divisional Director, Informa Life Sciences.
Asia is well-placed to grow in medical tourism as healthcare standards and technology adoption continue to improve. Hospitals in Korea, Malaysia, Thailand, India and Singapore have made it a point to implement state-of-the- art medical technologies to improve patient care.
Healthcare Travel Exhibition & Congress 2009 is Asia's premier event focusing on two of the world's largest industries: healthcare and tourism. The event brings together professionals, government officials and decision makers from the healthcare and travel industries, giving them the opportunity to network and share best practices, insights and knowledge to further develop Asia's thriving healthcare travel market.
Leading edge technology is on display at the exhibition portion of the
event, where close to 30 exhibitors including leading medical suppliers,
healthcar
'/>"/>
| SOURCE Informa Life Sciences Copyright©2009 PR Newswire. All rights reserved |